[1]
Boustany R.M., Zucker A.: Degenerative diseases primarily of gray matter.
W: Pediatric Neurology: principles and practice by K.F. Swaiman, S.
Ashwal, D.M. Ferriero, C.V.Mosby Co, Philadelphia 2006.
[2]
Rosenberg R.N., Prusiner S.B., DiMauro S. et.al.: Metabolizm metali. W:
Kliniczne kompendium do molekularnych i genetycznych podstaw chorób
neurologicznych. D.W. Publishing Co. 1999.
[3]
Swartz E.N.: A child with kinky hair. CMAJ, 2002:166, 1442–1443.
[4]
Olivares J.L., Bueno I., Gallati S. et al.: Late-onset treatment in Menkes
disease: is there a correlation between genotype and response to therapy?
Clin.Genet., 2006:69, 363–366.
[5]
Sheela S.R., Latha M., Liu P., Kaler S.G.: Copper-replacement treatment
for symptomatic Menkes disease: ethical considerations. Clin. Genet.,
2005:68, 278–283.
Adres do korespondencji:
Iwona Kochanowska, 70-892 Szczecin, ul. Buczynowa 4, e-mail: ikochanowska@onet.eu
[6]
Kim B.E., Smith K., Petris M.J.: A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper
ATPase. J. Med. Genet., 2003:40, 290–295.
[7]
Robain O., Aubourg P., Routon M.C. et al.: Menkes disease: a Golgi and
electron microscopic study of the cerebellar cortex. Clin. Neuropathol.,1988:7, 47–52.
[8]
Kaler S.G.: Menkes disease mutations and response to early copper histidine treatment. Nat. Genet., 1996:13, 21.
[9]
Westman J.A., Morrow G.: Treatment of Menkes disease with cupric chloride 1-histidine. Am. J. Hum. Genet., 1989:45 (Suppl.), 68.
Scholar Google
PubMed